{"title": "The Human Medicines Regulations 2012", "author": null, "url": null, "hostname": null, "description": "These Regulations consolidate the law of the United Kingdom concerning medicinal products for human use (\"products\") in respect of the topics described below.", "sitename": "King's Printer of Acts of Parliament", "date": "2016-09-14", "cleaned_text": "Original (As made) This is the original version (as it was originally made). [16.](/uksi/2012/1916/regulation/16/made) [Further provision about advisory bodies and expert advisory groups etc](/uksi/2012/1916/regulation/16/made) [19.](/uksi/2012/1916/regulation/19/made) [Exemptions from requirement for or wholesale dealer's licence](/uksi/2012/1916/regulation/22/made) [27.](/uksi/2012/1916/regulation/27/made) [Procedure where licensing authority proposes to suspend, revoke or vary licence](/uksi/2012/1916/regulation/27/made) [Application for UK marketing authorisation](/uksi/2012/1916/part/5/crossheading/application-for-uk-marketing-authorisation/made) [52.](/uksi/2012/1916/regulation/52/made) [Applications relating to certain medicinal products that do not qualify as generic etc](/uksi/2012/1916/regulation/52/made) [53.](/uksi/2012/1916/regulation/53/made) [Applications relating to similar biological medicinal products](/uksi/2012/1916/regulation/53/made) to products in well-established medicinal use](/uksi/2012/1916/regulation/54/made) relating to new combinations of active substances](/uksi/2012/1916/regulation/55/made) [56.](/uksi/2012/1916/regulation/56/made) [Applications containing information supplied in relation to another product with consent](/uksi/2012/1916/regulation/56/made) [57.](/uksi/2012/1916/regulation/57/made) [Obligation to update information supplied in connection with [Conditions of UK marketing authorisation: exceptional marketing authorisation: new obligations post-authorisation](/uksi/2012/1916/regulation/61/made) [Duties of licensing authority in connection with determination](/uksi/2012/1916/regulation/64/made) [Revocation, variation and suspension of marketing authorisation](/uksi/2012/1916/part/5/crossheading/revocation-variation-and-suspension-of-marketing-authorisation/made) [Obligations of holder of marketing authorisation](/uksi/2012/1916/part/5/crossheading/obligations-of-holder-of-marketing-authorisation/made) [74.](/uksi/2012/1916/regulation/74/made) [Obligation to take account of scientific and technical progress](/uksi/2012/1916/regulation/74/made) [Offences relating to EU marketing authorisations](/uksi/2012/1916/part/5/crossheading/offences-relating-to-eu-marketing-authorisations/made) [81.](/uksi/2012/1916/regulation/81/made) [Obligation to update information supplied in connection with EU application](/uksi/2012/1916/regulation/81/made) [82.](/uksi/2012/1916/regulation/82/made) [EU marketing authorisations: failure to notify placing on market etc](/uksi/2012/1916/regulation/82/made) [83.](/uksi/2012/1916/regulation/83/made) [EU marketing authorisations: failure to take account of technical and scientific progress](/uksi/2012/1916/regulation/83/made) [84.](/uksi/2012/1916/regulation/84/made) [EU marketing authorisations: failure to provide information as to safety etc](/uksi/2012/1916/regulation/84/made) [85.](/uksi/2012/1916/regulation/85/made) [EU marketing authorisations: failure to authorisations: the Paediatric Regulation](/uksi/2012/1916/part/5/crossheading/offences-relating-to-the-paediatric-regulation/made) [89.](/uksi/2012/1916/regulation/89/made) [Offences in with withdrawal of product from the market](/uksi/2012/1916/regulation/89/made) [90.](/uksi/2012/1916/regulation/90/made) [Failure to place on the market taking account of paediatric indication](/uksi/2012/1916/regulation/90/made) [91.](/uksi/2012/1916/regulation/91/made) [Failure to notify results of third country clinical trials](/uksi/2012/1916/regulation/91/made) [92.](/uksi/2012/1916/regulation/92/made) [Failure of sponsor of UK paediatric clinical trial to notify results of trial](/uksi/2012/1916/regulation/92/made) [Application for certificate of registration and consideration of application](/uksi/2012/1916/part/6/crossheading/application-for-certificate-of-registration-and-consideration-of-application/made) [Revocation, variation and suspension of certificate of registration](/uksi/2012/1916/part/6/crossheading/revocation-variation-and-suspension-of-certificate-of-registration/made) [Obligations of holder of certificate of registration](/uksi/2012/1916/part/6/crossheading/obligations-of-holder-of-certificate-of-registration/made) [114.](/uksi/2012/1916/regulation/114/made) [Obligation to take account of scientific and technical progress](/uksi/2012/1916/regulation/114/made) [115.](/uksi/2012/1916/regulation/115/made) [Obligation to provide information relating to safety etc](/uksi/2012/1916/regulation/115/made) [Revocation, variation and suspension of traditional herbal registration](/uksi/2012/1916/part/7/crossheading/revocation-variation-and-suspension-of-traditional-herbal-registration/made) [135.](/uksi/2012/1916/regulation/135/made) [Revocation, variation and suspension of traditional herbal registration](/uksi/2012/1916/regulation/135/made) [138.](/uksi/2012/1916/regulation/138/made) [Suspension of use etc of traditional herbal medicinal product](/uksi/2012/1916/regulation/138/made) [139.](/uksi/2012/1916/regulation/139/made) [Registrations granted under Chapter 4 of Title III of the 2001 Directive](/uksi/2012/1916/regulation/139/made) [140.](/uksi/2012/1916/regulation/140/made) [Withdrawal of traditional herbal medicinal product from the market](/uksi/2012/1916/regulation/140/made) [141.](/uksi/2012/1916/regulation/141/made) [Sale etc of suspended traditional herbal medicinal product](/uksi/2012/1916/regulation/141/made) [Obligations of holder of traditional herbal registration](/uksi/2012/1916/part/7/crossheading/obligations-of-holder-of-traditional-herbal-registration/made) [143.](/uksi/2012/1916/regulation/143/made) [Obligation to take account of scientific and technical progress](/uksi/2012/1916/regulation/143/made) [145.](/uksi/2012/1916/regulation/145/made) [Obligation to provide information relating to safety etc](/uksi/2012/1916/regulation/145/made) [168.](/uksi/2012/1916/regulation/168/made) [Use of non-prescription medicines in the course of a business](/uksi/2012/1916/regulation/168/made) [Obligations on licensing authority in relation to pharmacovigilance](/uksi/2012/1916/part/11/crossheading/obligations-on-licensing-authority-in-relation-to-pharmacovigilance/made) [Obligations on holders in relation to pharmacovigilance system](/uksi/2012/1916/part/11/crossheading/obligations-on-holders-in-relation-to-pharmacovigilance-system/made) [Recording, Update Reports](/uksi/2012/1916/part/11/crossheading/periodic-safety-update-reports/made) [191.](/uksi/2012/1916/regulation/191/made) [Obligation on periodic safety update reports: general requirements](/uksi/2012/1916/regulation/191/made) [192.](/uksi/2012/1916/regulation/192/made) [Obligation on holder to submit periodic safety update reports: derogation from general requirements](/uksi/2012/1916/regulation/192/made) [194.](/uksi/2012/1916/regulation/194/made) [Responding to a single assessment of PSUR under Article 107e of the 2001 Directive](/uksi/2012/1916/regulation/194/made) [195.](/uksi/2012/1916/regulation/195/made) [Obligation on licensing authority to assess PSURs where EU single assessment procedure does not apply](/uksi/2012/1916/regulation/195/made) [Exemptions relating to supply in specific circumstances](/uksi/2012/1916/part/12/chapter/3/crossheading/exemptions-relating-to-supply-in-specific-circumstances/made) [224.](/uksi/2012/1916/regulation/224/made) [Emergency by pharmacist: prescriber unable to provide prescription](/uksi/2012/1916/regulation/224/made) [228.](/uksi/2012/1916/regulation/228/made) [Exemptions relating to prescriptions given by certain health professionals](/uksi/2012/1916/regulation/228/made) [230.](/uksi/2012/1916/regulation/230/made) [Exemption for supply etc under a PGD to assist doctors or dentists](/uksi/2012/1916/regulation/230/made) [231.](/uksi/2012/1916/regulation/231/made) [Exemption for supply etc under a PGD by independent hospitals etc](/uksi/2012/1916/regulation/231/made) [232.](/uksi/2012/1916/regulation/232/made) [Exemption for supply etc under a PGD by dental practices and clinics: England and Wales](/uksi/2012/1916/regulation/232/made) [233.](/uksi/2012/1916/regulation/233/made) [Exemption for supply etc under a PGD by person conducting a retail pharmacy business](/uksi/2012/1916/regulation/233/made) [234.](/uksi/2012/1916/regulation/234/made) [Exemption for supply etc of products under a PGD to assist the police etc](/uksi/2012/1916/regulation/234/made) [235.](/uksi/2012/1916/regulation/235/made) [Exemption for sale, supply or administration by certain persons](/uksi/2012/1916/regulation/235/made) [Exemptions in relation to specific kinds of product](/uksi/2012/1916/part/12/chapter/3/crossheading/exemptions-in-relation-to-specific-kinds-of-product/made) [236.](/uksi/2012/1916/regulation/236/made) [Products consisting of or containing aloxiprin, aspirin [Products consisting of base or salts](/uksi/2012/1916/regulation/237/made) [249.](/uksi/2012/1916/regulation/249/made) [Restrictions to be supplied with medicinal products](/uksi/2012/1916/regulation/249/made) [251.](/uksi/2012/1916/regulation/251/made) [Compliance with standards specified in certain publications](/uksi/2012/1916/regulation/251/made) specified in certain publications: supplementary](/uksi/2012/1916/regulation/252/made) [254.](/uksi/2012/1916/regulation/254/made) [Prohibitions concerning traceability of treatment with advanced therapy medicinal products](/uksi/2012/1916/regulation/254/made) [Requirements for packaging and package leaflets relating to medicinal products](/uksi/2012/1916/part/13/chapter/1/crossheading/requirements-for-packaging-and-package-leaflets-relating-to-medicinal-products/made) [259.](/uksi/2012/1916/regulation/259/made) [Packaging requirements: information for blind and partially sighted [Additional requirements for traditional herbal medicinal products](/uksi/2012/1916/regulation/265/made) [267.](/uksi/2012/1916/regulation/267/made) [Submission of mock-ups of packaging and leaflets to licensing authority](/uksi/2012/1916/regulation/267/made) [Prohibition of supply to the public [Regulation ](/uksi/2012/1916/regulation/328/made) [327](): supplementary [329.](/uksi/2012/1916/regulation/329/made) [Application of sampling to substance or article seized under this Part](/uksi/2012/1916/regulation/329/made) [Transitional provisions, savings, amendments, repeals and revocations](/uksi/2012/1916/part/17/crossheading/transitional-provisions-savings-amendments-repeals-and-revocations/made) SCHEDULES [Further provisions for classification of medicinal products](/uksi/2012/1916/schedule/1/made) [PART 1 Descriptions of certain medicinal products to be available only on prescription](/uksi/2012/1916/schedule/1/part/1/made) [PART 2 Descriptions of certain medicinal products to be available only from a pharmacy](/uksi/2012/1916/schedule/1/part/2/made) [Supplementary provision relating to advisory bodies and expert advisory groups](/uksi/2012/1916/schedule/2/made) [Applications for licences under Part 3](/uksi/2012/1916/schedule/3/made) Part relating to manufacture and assembly](/uksi/2012/1916/schedule/4/part/1/made) [1.](/uksi/2012/1916/schedule/4/paragraph/1/made) [The provisions of this Part are standard provisions of a...](/uksi/2012/1916/schedule/4/paragraph/1/made) [2.](/uksi/2012/1916/schedule/4/paragraph/2/made) [The licence holder must place the quality control system referred...](/uksi/2012/1916/schedule/4/paragraph/2/made) [3.](/uksi/2012/1916/schedule/4/paragraph/3/made) [The licence holder may use a contract laboratory pursuant to...](/uksi/2012/1916/schedule/4/paragraph/3/made) [4.](/uksi/2012/1916/schedule/4/paragraph/4/made) [The licence holder must provide such information as may be...](/uksi/2012/1916/schedule/4/paragraph/4/made) [5.](/uksi/2012/1916/schedule/4/paragraph/5/made) [The licence holder must inform any...](/uksi/2012/1916/schedule/4/paragraph/5/made) [6.](/uksi/2012/1916/schedule/4/paragraph/6/made) [The licence holder inspection...](/uksi/2012/1916/schedule/4/paragraph/6/made) [7.](/uksi/2012/1916/schedule/4/paragraph/7/made) [The licence holder must keep readily available for examination by...](/uksi/2012/1916/schedule/4/paragraph/7/made) [8.](/uksi/2012/1916/schedule/4/paragraph/8/made) [Where the licence holder has been informed by the licensing...](/uksi/2012/1916/schedule/4/paragraph/8/made) [9.](/uksi/2012/1916/schedule/4/paragraph/9/made) [The licence holder must ensure conformity...](/uksi/2012/1916/schedule/4/paragraph/9/made) [10.](/uksi/2012/1916/schedule/4/paragraph/10/made) [Where the manufacturer's licence relates [11.](/uksi/2012/1916/schedule/4/paragraph/11/made) [Where\u2014 of...](/uksi/2012/1916/schedule/4/paragraph/11/made) [12.](/uksi/2012/1916/schedule/4/paragraph/12/made) [The licence must keep readily available for examination by...](/uksi/2012/1916/schedule/4/paragraph/12/made) [13.](/uksi/2012/1916/schedule/4/paragraph/13/made) [Where\u2014 (a) animals are used in the production of medicinal...](/uksi/2012/1916/schedule/4/paragraph/13/made) [14.](/uksi/2012/1916/schedule/4/paragraph/14/made) [The licence holder must take all reasonable precautions and exercise...](/uksi/2012/1916/schedule/4/paragraph/14/made) [PART 2 Manufacturer's licence relating to the import of medicinal products from a state other than an EEA State](/uksi/2012/1916/schedule/4/part/2/made) [15.](/uksi/2012/1916/schedule/4/paragraph/15/made) [The provisions of this Part are standard provisions of a...](/uksi/2012/1916/schedule/4/paragraph/15/made) [16.](/uksi/2012/1916/schedule/4/paragraph/16/made) [The licence holder must place the quality control system referred...](/uksi/2012/1916/schedule/4/paragraph/16/made) [17.](/uksi/2012/1916/schedule/4/paragraph/17/made) [The licence holder may use a contract laboratory pursuant to...](/uksi/2012/1916/schedule/4/paragraph/17/made) [18.](/uksi/2012/1916/schedule/4/paragraph/18/made) [The licence holder must provide be...](/uksi/2012/1916/schedule/4/paragraph/18/made) [19.](/uksi/2012/1916/schedule/4/paragraph/19/made) [The licence holder must\u2014 inspection...](/uksi/2012/1916/schedule/4/paragraph/19/made) [20.](/uksi/2012/1916/schedule/4/paragraph/20/made) [Where the licence holder has been informed by the licensing...](/uksi/2012/1916/schedule/4/paragraph/20/made) [21.](/uksi/2012/1916/schedule/4/paragraph/21/made) [The licence holder must ensure that any tests for determining...](/uksi/2012/1916/schedule/4/paragraph/21/made) [23.](/uksi/2012/1916/schedule/4/paragraph/23/made) [The licence holder must take all reasonable precautions and exercise...](/uksi/2012/1916/schedule/4/paragraph/23/made) [PART 3 Manufacturer's licence relating to exempt Wholesale dealer's medicinal products](/uksi/2012/1916/schedule/4/part/4/crossheading/wholesale-dealers-licence-relating-to-special-medicinal-products/made) [32.](/uksi/2012/1916/schedule/4/paragraph/32/made) [The provisions of paragraphs 33 to 42 are incorporated as...](/uksi/2012/1916/schedule/4/paragraph/32/made) [35.](/uksi/2012/1916/schedule/4/paragraph/35/made) [The licence holder may not import the special medicinal product...](/uksi/2012/1916/schedule/4/paragraph/35/made) [36.](/uksi/2012/1916/schedule/4/paragraph/36/made) [The licence holder may import the special medicinal product referred...](/uksi/2012/1916/schedule/4/paragraph/36/made) [37.](/uksi/2012/1916/schedule/4/paragraph/37/made) [Where the licence holder sells or supplies special medicinal products,...](/uksi/2012/1916/schedule/4/paragraph/37/made) [38.](/uksi/2012/1916/schedule/4/paragraph/38/made) [The licence holder must not, on any one occasion, import...](/uksi/2012/1916/schedule/4/paragraph/38/made) [39.](/uksi/2012/1916/schedule/4/paragraph/39/made) [The licence holder must inform the licensing authority immediately of...](/uksi/2012/1916/schedule/4/paragraph/39/made) [40.](/uksi/2012/1916/schedule/4/paragraph/40/made) [The licence holder or...](/uksi/2012/1916/schedule/4/paragraph/40/made) [41.](/uksi/2012/1916/schedule/4/paragraph/41/made) [The licence holder must [42.](/uksi/2012/1916/schedule/4/paragraph/42/made) [In this relating to advanced therapy upon oral representations](/uksi/2012/1916/schedule/5/made) [Manufacturer's and wholesale dealer's licences](/uksi/2012/1916/schedule/6/part/1/made) [2.](/uksi/2012/1916/schedule/6/paragraph/2/made) [The of any...](/uksi/2012/1916/schedule/6/paragraph/2/made) [3.](/uksi/2012/1916/schedule/6/paragraph/3/made) [The licence holder must ensure, if using human cells or...](/uksi/2012/1916/schedule/6/paragraph/3/made) [4.](/uksi/2012/1916/schedule/6/paragraph/4/made) [The licence holder must ensure that any human or...](/uksi/2012/1916/schedule/6/paragraph/4/made) [6.](/uksi/2012/1916/schedule/6/paragraph/6/made) [Where the holder way...](/uksi/2012/1916/schedule/6/paragraph/6/made) [8.](/uksi/2012/1916/schedule/6/paragraph/8/made) [The licence maintain a system ensuring...](/uksi/2012/1916/schedule/6/paragraph/8/made) [9.](/uksi/2012/1916/schedule/6/paragraph/9/made) [The licence holder must, subject to paragraph 27 of Schedule...](/uksi/2012/1916/schedule/6/paragraph/9/made) [10.](/uksi/2012/1916/schedule/6/paragraph/10/made) [The licence holder must secure that the data referred to...](/uksi/2012/1916/schedule/6/paragraph/10/made) [11.](/uksi/2012/1916/schedule/6/paragraph/11/made) [The licence holder must, where an exempt advanced therapy medicinal...](/uksi/2012/1916/schedule/6/paragraph/11/made) [12.](/uksi/2012/1916/schedule/6/paragraph/12/made) [The licence holder must not import 2 Wholesale dealer's licences](/uksi/2012/1916/schedule/6/part/2/made) [14.](/uksi/2012/1916/schedule/6/paragraph/14/made) [The advanced therapy...](/uksi/2012/1916/schedule/6/paragraph/14/made) [15.](/uksi/2012/1916/schedule/6/paragraph/15/made) [The licence holder must distribute an exempt advanced therapy medicinal...](/uksi/2012/1916/schedule/6/paragraph/15/made) [16.](/uksi/2012/1916/schedule/6/paragraph/16/made) [The licence holder must establish and maintain a system ensuring...](/uksi/2012/1916/schedule/6/paragraph/16/made) [17.](/uksi/2012/1916/schedule/6/paragraph/17/made) [The licence holder must inform the licensing authority of any...](/uksi/2012/1916/schedule/6/paragraph/17/made) [18.](/uksi/2012/1916/schedule/6/paragraph/18/made) [The licence holder must, subject to paragraph 44 of Schedule...](/uksi/2012/1916/schedule/6/paragraph/18/made) [19.](/uksi/2012/1916/schedule/6/paragraph/19/made) [The licence holder must secure that the data referred to...](/uksi/2012/1916/schedule/6/paragraph/19/made) [20.](/uksi/2012/1916/schedule/6/paragraph/20/made) [The licence holder must not import or export any exempt...](/uksi/2012/1916/schedule/6/paragraph/20/made) [PART 1 Qualification requirements for qualified person](/uksi/2012/1916/schedule/7/part/1/made) [1.](/uksi/2012/1916/schedule/7/paragraph/1/made) [A person must satisfy the requirements in paragraphs 2 and...](/uksi/2012/1916/schedule/7/paragraph/1/made) [3.](/uksi/2012/1916/schedule/7/paragraph/3/made) [A qualification satisfies the requirements of this Part if it...](/uksi/2012/1916/schedule/7/paragraph/3/made) [4.](/uksi/2012/1916/schedule/7/paragraph/4/made) [(1) A course should include at least the following core...](/uksi/2012/1916/schedule/7/paragraph/4/made) [6.](/uksi/2012/1916/schedule/7/paragraph/6/made) [If two university courses, or courses recognised as of university...](/uksi/2012/1916/schedule/7/paragraph/6/made) [7.](/uksi/2012/1916/schedule/7/paragraph/7/made) [If the person's formal qualifications do not satisfy the requirements...](/uksi/2012/1916/schedule/7/paragraph/7/made) [8.](/uksi/2012/1916/schedule/7/paragraph/8/made) [(1) The person must (subject to sub-paragraph (2)) have at...](/uksi/2012/1916/schedule/7/paragraph/8/made) [Material to accompany an application for a UK marketing authorisation](/uksi/2012/1916/schedule/8/made) [1.](/uksi/2012/1916/schedule/8/paragraph/1/made) [The name or corporate name and permanent address of the...](/uksi/2012/1916/schedule/8/paragraph/1/made) [3.](/uksi/2012/1916/schedule/8/paragraph/3/made) [Qualitative and quantitative particulars of the constituents of the medicinal...](/uksi/2012/1916/schedule/8/paragraph/3/made) [4.](/uksi/2012/1916/schedule/8/paragraph/4/made) [An evaluation of the potential environmental risks posed by the...](/uksi/2012/1916/schedule/8/paragraph/4/made) [5.](/uksi/2012/1916/schedule/8/paragraph/5/made) [A description of the methods of manufacturing the medicinal product....](/uksi/2012/1916/schedule/8/paragraph/5/made) [6.](/uksi/2012/1916/schedule/8/paragraph/6/made) [The therapeutic indications and contra-indications for the medicinal product and...](/uksi/2012/1916/schedule/8/paragraph/6/made) [7.](/uksi/2012/1916/schedule/8/paragraph/7/made) [The posology and pharmaceutical form of the medicinal product, its...](/uksi/2012/1916/schedule/8/paragraph/7/made) [8.](/uksi/2012/1916/schedule/8/paragraph/8/made) [The reasons for any precautionary and safety measures to be...](/uksi/2012/1916/schedule/8/paragraph/8/made) [9.](/uksi/2012/1916/schedule/8/paragraph/9/made) [A description of the control methods employed by the manufacturer....](/uksi/2012/1916/schedule/8/paragraph/9/made) [10.](/uksi/2012/1916/schedule/8/paragraph/10/made) [The results of the following in relation to the medicinal...](/uksi/2012/1916/schedule/8/paragraph/10/made) [11.](/uksi/2012/1916/schedule/8/paragraph/11/made) [A detailed summary of those results prepared and signed by...](/uksi/2012/1916/schedule/8/paragraph/11/made) [12.](/uksi/2012/1916/schedule/8/paragraph/12/made) [A summary of the applicant's pharmacovigilance system which shall include...](/uksi/2012/1916/schedule/8/paragraph/12/made) [14.](/uksi/2012/1916/schedule/8/paragraph/14/made) [Where any clinical trials have been carried out outside the...](/uksi/2012/1916/schedule/8/paragraph/14/made) [15.](/uksi/2012/1916/schedule/8/paragraph/15/made) [A summary of the product characteristics for the medicinal product...](/uksi/2012/1916/schedule/8/paragraph/15/made) [16.](/uksi/2012/1916/schedule/8/paragraph/16/made) [A mock-up, in accordance with Part 13 (packaging and leaflets)...](/uksi/2012/1916/schedule/8/paragraph/16/made) [17.](/uksi/2012/1916/schedule/8/paragraph/17/made) [A document showing that the manufacturer of the medicinal product...](/uksi/2012/1916/schedule/8/paragraph/17/made) [18.](/uksi/2012/1916/schedule/8/paragraph/18/made) [Where an application for authorisation for the medicinal product to...](/uksi/2012/1916/schedule/8/paragraph/18/made) [19.](/uksi/2012/1916/schedule/8/paragraph/19/made) [Where an authorisation for the medicinal product to be placed...](/uksi/2012/1916/schedule/8/paragraph/19/made) [20.](/uksi/2012/1916/schedule/8/paragraph/20/made) [Where an authorisation for the medicinal product to be placed...](/uksi/2012/1916/schedule/8/paragraph/20/made) [21.](/uksi/2012/1916/schedule/8/paragraph/21/made) [Where an authorisation for the [Undertakings by non-EEA manufacturers](/uksi/2012/1916/schedule/9/made) [1.](/uksi/2012/1916/schedule/9/paragraph/1/made) [The manufacturer maintain such staff, premises and...](/uksi/2012/1916/schedule/9/paragraph/1/made) [2.](/uksi/2012/1916/schedule/9/paragraph/2/made) [The manufacturer must provide and maintain such staff, premises, equipment...](/uksi/2012/1916/schedule/9/paragraph/2/made) [3.](/uksi/2012/1916/schedule/9/paragraph/3/made) [The manufacturer must provide and maintain a designated quality control...](/uksi/2012/1916/schedule/9/paragraph/3/made) [4.](/uksi/2012/1916/schedule/9/paragraph/4/made) [The manufacturer must conduct all manufacture and assembly operations in...](/uksi/2012/1916/schedule/9/paragraph/4/made) [5.](/uksi/2012/1916/schedule/9/paragraph/5/made) [The manufacturer must maintain an effective pharmaceutical quality assurance system...](/uksi/2012/1916/schedule/9/paragraph/5/made) [6.](/uksi/2012/1916/schedule/9/paragraph/6/made) [Where animals are used in the production of any medicinal...](/uksi/2012/1916/schedule/9/paragraph/6/made) [7.](/uksi/2012/1916/schedule/9/paragraph/7/made) [The manufacturer must make such adequate and suitable arrangements as...](/uksi/2012/1916/schedule/9/paragraph/7/made) [8.](/uksi/2012/1916/schedule/9/paragraph/8/made) [The manufacturer must inform the holder of the marketing authorisation...](/uksi/2012/1916/schedule/9/paragraph/8/made) [9.](/uksi/2012/1916/schedule/9/paragraph/9/made) [(1) The manufacturer shall keep readily available for inspection by...](/uksi/2012/1916/schedule/9/paragraph/9/made) [10.](/uksi/2012/1916/schedule/9/paragraph/10/made) [The manufacturer must keep readily available for examination by a...](/uksi/2012/1916/schedule/9/paragraph/10/made) [11.](/uksi/2012/1916/schedule/9/paragraph/11/made) [(1) The manufacturer must implement a system for recording and...](/uksi/2012/1916/schedule/9/paragraph/11/made) [12.](/uksi/2012/1916/schedule/9/paragraph/12/made) [The manufacturer must inform the holder of the marketing authorisation...](/uksi/2012/1916/schedule/9/paragraph/12/made) [National homoeopathic products](/uksi/2012/1916/schedule/10/made) [Right to review or representations after paragraph 12 notification](/uksi/2012/1916/schedule/11/part/1/crossheading/right-to-review-or-representations-after-paragraph-12-notification/made) [PART 2 Type II variation applications, complex variation applications and new excipient variation applications](/uksi/2012/1916/schedule/11/part/2/made) [PART 3 Referral to the Committee for Herbal Medicinal Products](/uksi/2012/1916/schedule/11/part/3/made) [31.](/uksi/2012/1916/schedule/11/paragraph/31/made) [This Schedule does not apply to an application for the...](/uksi/2012/1916/schedule/11/paragraph/31/made) [32.](/uksi/2012/1916/schedule/11/paragraph/32/made) [This Schedule does not apply to an application for the...](/uksi/2012/1916/schedule/11/paragraph/32/made) [36.](/uksi/2012/1916/schedule/11/paragraph/36/made) [This Schedule does not apply if the application or proposal...](/uksi/2012/1916/schedule/11/paragraph/36/made) [37.](/uksi/2012/1916/schedule/11/paragraph/37/made) [This Schedule does not apply if the application or proposal...](/uksi/2012/1916/schedule/11/paragraph/37/made) [38.](/uksi/2012/1916/schedule/11/paragraph/38/made) [This Schedule does not apply if the application or proposal...](/uksi/2012/1916/schedule/11/paragraph/38/made) [39.](/uksi/2012/1916/schedule/11/paragraph/39/made) [This Schedule does not apply if\u2014 (a) the licensing authority...](/uksi/2012/1916/schedule/11/paragraph/39/made) [Material to accompany an application for a traditional herbal registration](/uksi/2012/1916/schedule/12/made) [1.](/uksi/2012/1916/schedule/12/paragraph/1/made) [The name or corporate name and permanent address of the...](/uksi/2012/1916/schedule/12/paragraph/1/made) [3.](/uksi/2012/1916/schedule/12/paragraph/3/made) [Qualitative and quantitative particulars of the constituents of the medicinal...](/uksi/2012/1916/schedule/12/paragraph/3/made) [4.](/uksi/2012/1916/schedule/12/paragraph/4/made) [An evaluation of the potential environmental risks posed by the...](/uksi/2012/1916/schedule/12/paragraph/4/made) [5.](/uksi/2012/1916/schedule/12/paragraph/5/made) [A description of the methods of manufacturing the medicinal product....](/uksi/2012/1916/schedule/12/paragraph/5/made) [6.](/uksi/2012/1916/schedule/12/paragraph/6/made) [The therapeutic indications and contra-indications for the medicinal product and...](/uksi/2012/1916/schedule/12/paragraph/6/made) [7.](/uksi/2012/1916/schedule/12/paragraph/7/made) [The posology and pharmaceutical form of the medicinal product, its...](/uksi/2012/1916/schedule/12/paragraph/7/made) [8.](/uksi/2012/1916/schedule/12/paragraph/8/made) [The reasons for any precautionary and safety measures to be...](/uksi/2012/1916/schedule/12/paragraph/8/made) [9.](/uksi/2012/1916/schedule/12/paragraph/9/made) [A description of the control methods employed manufacturer....](/uksi/2012/1916/schedule/12/paragraph/9/made) [10.](/uksi/2012/1916/schedule/12/paragraph/10/made) [Results of to...](/uksi/2012/1916/schedule/12/paragraph/10/made) [11.](/uksi/2012/1916/schedule/12/paragraph/11/made) [A detailed summary of those results prepared and signed by...](/uksi/2012/1916/schedule/12/paragraph/11/made) [12.](/uksi/2012/1916/schedule/12/paragraph/12/made) [A summary of the product characteristics for the medicinal product...](/uksi/2012/1916/schedule/12/paragraph/12/made) [13.](/uksi/2012/1916/schedule/12/paragraph/13/made) [A mock-up, in accordance with Part 13 (packaging and leaflets)...](/uksi/2012/1916/schedule/12/paragraph/13/made) [14.](/uksi/2012/1916/schedule/12/paragraph/14/made) [A document showing that the manufacturer of the medicinal product...](/uksi/2012/1916/schedule/12/paragraph/14/made) [15.](/uksi/2012/1916/schedule/12/paragraph/15/made) [Where the medicinal product consists of a combination of one...](/uksi/2012/1916/schedule/12/paragraph/15/made) [16.](/uksi/2012/1916/schedule/12/paragraph/16/made) [Details of any authorisation or registration obtained by the applicant...](/uksi/2012/1916/schedule/12/paragraph/16/made) [18.](/uksi/2012/1916/schedule/12/paragraph/18/made) [Bibliographical or expert evidence of the traditional use of the...](/uksi/2012/1916/schedule/12/paragraph/18/made) [Prescription only medicines for which community practitioner nurse prescribers are appropriate practitioners](/uksi/2012/1916/schedule/13/made) [Prescription etc by supplementary prescribers: particulars of clinical management plan](/uksi/2012/1916/schedule/14/made) [PART 1 Particulars to be included in a patient group direction](/uksi/2012/1916/schedule/16/part/1/made) [1.](/uksi/2012/1916/schedule/16/paragraph/1/made) [The period during which the direction is to have effect....](/uksi/2012/1916/schedule/16/paragraph/1/made) [2.](/uksi/2012/1916/schedule/16/paragraph/2/made) [The description or class of medicinal product to which the...](/uksi/2012/1916/schedule/16/paragraph/2/made) [3.](/uksi/2012/1916/schedule/16/paragraph/3/made) [The clinical situations which medicinal products of that description or...](/uksi/2012/1916/schedule/16/paragraph/3/made) [4.](/uksi/2012/1916/schedule/16/paragraph/4/made) [Whether there are any restrictions on the quantity of medicinal...](/uksi/2012/1916/schedule/16/paragraph/4/made) [6.](/uksi/2012/1916/schedule/16/paragraph/6/made) [Whether any class of person is excluded from treatment under...](/uksi/2012/1916/schedule/16/paragraph/6/made) [7.](/uksi/2012/1916/schedule/16/paragraph/7/made) [Whether there are circumstances in which further advice should be...](/uksi/2012/1916/schedule/16/paragraph/7/made) [8.](/uksi/2012/1916/schedule/16/paragraph/8/made) [The pharmaceutical form or forms in which medicinal products of...](/uksi/2012/1916/schedule/16/paragraph/8/made) [9.](/uksi/2012/1916/schedule/16/paragraph/9/made) [The strength, or maximum strength, at which medicinal products of...](/uksi/2012/1916/schedule/16/paragraph/9/made) [13.](/uksi/2012/1916/schedule/16/paragraph/13/made) [Any minimum or maximum period of administration applicable to medicinal...](/uksi/2012/1916/schedule/16/paragraph/13/made) [14.](/uksi/2012/1916/schedule/16/paragraph/14/made) [Whether there are any relevant warnings to note and, if...](/uksi/2012/1916/schedule/16/paragraph/14/made) [PART 2 Persons on whose behalf a patient group Direction must be signed](/uksi/2012/1916/schedule/16/part/2/made) [PART 3 Persons by whom or on whose behalf a patient group direction used as described in regulation ](/uksi/2012/1916/schedule/16/part/3/made) [234]() must be signed [Exemption for sale, supply or administration by certain persons](/uksi/2012/1916/schedule/17/made) [PART 1 Exemption from restrictions on sale and supply of prescription only medicines](/uksi/2012/1916/schedule/17/part/1/made) [PART 2 Exemption from the restriction on supply of prescription only medicines](/uksi/2012/1916/schedule/17/part/2/made) [PART 3 Exemptions from the restriction on administration of prescription only medicines](/uksi/2012/1916/schedule/17/part/3/made) [PART 4 Exemptions from the restrictions in regulations ](/uksi/2012/1916/schedule/17/part/4/made) [220]() and [221]() for certain persons who sell, supply, or offer for sale or supply certain medicinal products [PART 5 Exemptions from the restrictions in regulations ](/uksi/2012/1916/schedule/17/part/5/made) [220]() and [221]() for certain persons who supply certain medicinal products [Substances that may not be sold or supplied by a pharmacist without a prescription in reliance on regulation ](/uksi/2012/1916/schedule/18/made) [225]() [Medicinal products for parenteral administration in an emergency](/uksi/2012/1916/schedule/19/made) [Herbal medicinal products specified for the purposes of regulation ](/uksi/2012/1916/schedule/20/made) [241]() [Medicinal products at high dilutions](/uksi/2012/1916/schedule/21/made) [PART 1 Dilutions of unit preparations diluted to at least one part in a thousand (3x)](/uksi/2012/1916/schedule/21/part/1/made) [PART 2 Dilutions of unit preparations diluted to at least one part in a million (6x)](/uksi/2012/1916/schedule/21/part/2/made) [PART 3 Dilutions of unit preparations diluted to at least one part in ten (1x)](/uksi/2012/1916/schedule/21/part/3/made) [PART 4 Dilutions of unit preparations diluted to at least one part in ten (1x) for external use](/uksi/2012/1916/schedule/21/part/4/made) [Particulars in pharmacy records](/uksi/2012/1916/schedule/23/made) [1.](/uksi/2012/1916/schedule/23/paragraph/1/made) [Paragraph 2 applies, subject to paragraph 3, where the sale...](/uksi/2012/1916/schedule/23/paragraph/1/made) [2.](/uksi/2012/1916/schedule/23/paragraph/2/made) [In such a case, the particulars referred to in regulation...](/uksi/2012/1916/schedule/23/paragraph/2/made) [4.](/uksi/2012/1916/schedule/23/paragraph/4/made) [Where the sale or supply of a prescription only medicine...](/uksi/2012/1916/schedule/23/paragraph/4/made) [6.](/uksi/2012/1916/schedule/23/paragraph/6/made) [In such a case, the particulars referred to in regulation...](/uksi/2012/1916/schedule/23/paragraph/6/made) [Packaging information requirements](/uksi/2012/1916/schedule/24/made) [PART 1 Outer and immediate packaging](/uksi/2012/1916/schedule/24/part/1/made) [3.](/uksi/2012/1916/schedule/24/paragraph/3/made) [Where appropriate, whether the product is intended for babies, children...](/uksi/2012/1916/schedule/24/paragraph/3/made) [4.](/uksi/2012/1916/schedule/24/paragraph/4/made) [Where the product contains up to three active substances, the...](/uksi/2012/1916/schedule/24/paragraph/4/made) [5.](/uksi/2012/1916/schedule/24/paragraph/5/made) [A statement of the active substances in the product, expressed...](/uksi/2012/1916/schedule/24/paragraph/5/made) [6.](/uksi/2012/1916/schedule/24/paragraph/6/made) [The pharmaceutical form and the contents by weight, by volume...](/uksi/2012/1916/schedule/24/paragraph/6/made) [8.](/uksi/2012/1916/schedule/24/paragraph/8/made) [The method of administration of the product and if necessary...](/uksi/2012/1916/schedule/24/paragraph/8/made) [9.](/uksi/2012/1916/schedule/24/paragraph/9/made) [Where appropriate, space for the prescribed dose to be indicated....](/uksi/2012/1916/schedule/24/paragraph/9/made) [12.](/uksi/2012/1916/schedule/24/paragraph/12/made) [The product's expiry date (month and year), in clear terms....](/uksi/2012/1916/schedule/24/paragraph/12/made) [14.](/uksi/2012/1916/schedule/24/paragraph/14/made) [Any special precautions relating to the disposal of an unused...](/uksi/2012/1916/schedule/24/paragraph/14/made) [16.](/uksi/2012/1916/schedule/24/paragraph/16/made) [The [21.](/uksi/2012/1916/schedule/24/paragraph/21/made) the product is intended for babies, children...](/uksi/2012/1916/schedule/24/paragraph/21/made) [22.](/uksi/2012/1916/schedule/24/paragraph/22/made) [Where the product contains up to three active substances, the...](/uksi/2012/1916/schedule/24/paragraph/22/made) [23.](/uksi/2012/1916/schedule/24/paragraph/23/made) [The name of the holder of the marketing authorisation, Article...](/uksi/2012/1916/schedule/24/paragraph/23/made) [24.](/uksi/2012/1916/schedule/24/paragraph/24/made) [The product's expiry date (month and [PART 3 Immediate packaging: small packages](/uksi/2012/1916/schedule/24/part/3/made) [28.](/uksi/2012/1916/schedule/24/paragraph/28/made) [Where appropriate, the product is intended for babies, children...](/uksi/2012/1916/schedule/24/paragraph/28/made) [29.](/uksi/2012/1916/schedule/24/paragraph/29/made) [Where the product contains up to three active substances, the...](/uksi/2012/1916/schedule/24/paragraph/29/made) [30.](/uksi/2012/1916/schedule/24/paragraph/30/made) [The method of administration of the product and if necessary...](/uksi/2012/1916/schedule/24/paragraph/30/made) [31.](/uksi/2012/1916/schedule/24/paragraph/31/made) [The product's expiry date (month specific provisions](/uksi/2012/1916/schedule/25/made) [PART 1 Medicines on prescription](/uksi/2012/1916/schedule/25/part/1/made) [1.](/uksi/2012/1916/schedule/25/paragraph/1/made) [Where the product is to be administered to a particular...](/uksi/2012/1916/schedule/25/paragraph/1/made) [4.](/uksi/2012/1916/schedule/25/paragraph/4/made) [Unless paragraph 5, applies, such of the following particulars as...](/uksi/2012/1916/schedule/25/paragraph/4/made) [5.](/uksi/2012/1916/schedule/25/paragraph/5/made) [This paragraph applies if the pharmacist, in the exercise of...](/uksi/2012/1916/schedule/25/paragraph/5/made) [6.](/uksi/2012/1916/schedule/25/paragraph/6/made) [Where paragraph 5 applies, the pharmacist may particulars,...](/uksi/2012/1916/schedule/25/paragraph/6/made) [PART 4 Medicines containing paracetamol](/uksi/2012/1916/schedule/25/part/4/made) [14.](/uksi/2012/1916/schedule/25/paragraph/14/made) [If the paracetamol, except where the name of...](/uksi/2012/1916/schedule/25/paragraph/14/made) [15.](/uksi/2012/1916/schedule/25/paragraph/15/made) [If the paracetamol the take...](/uksi/2012/1916/schedule/25/paragraph/15/made) [16.](/uksi/2012/1916/schedule/25/paragraph/16/made) [If the paracetamol, unless product is wholly...](/uksi/2012/1916/schedule/25/paragraph/16/made) [17.](/uksi/2012/1916/schedule/25/paragraph/17/made) [If the product contains paracetamol [Packaging requirements: special provisions](/uksi/2012/1916/schedule/26/made) [5.](/uksi/2012/1916/schedule/26/paragraph/5/made) [Where the be administered to a particular...](/uksi/2012/1916/schedule/26/paragraph/5/made) [8.](/uksi/2012/1916/schedule/26/paragraph/8/made) [Where the product is prescribed by an appropriate practitioner, such...](/uksi/2012/1916/schedule/26/paragraph/8/made) [9.](/uksi/2012/1916/schedule/26/paragraph/9/made) [This paragraph applies if a pharmacist, in the exercise of...](/uksi/2012/1916/schedule/26/paragraph/9/made) [10.](/uksi/2012/1916/schedule/26/paragraph/10/made) [Where paragraph 9 applies, the pharmacist may include such particulars,...](/uksi/2012/1916/schedule/26/paragraph/10/made) [11.](/uksi/2012/1916/schedule/26/paragraph/11/made) [Where the product is not prescribed by an appropriate practitioner,...](/uksi/2012/1916/schedule/26/paragraph/11/made) [3.](/uksi/2012/1916/schedule/27/paragraph/3/made) [Where appropriate, whether the product is intended for babies, children...](/uksi/2012/1916/schedule/27/paragraph/3/made) [4.](/uksi/2012/1916/schedule/27/paragraph/4/made) [Where the product contains up to three active substances, the...](/uksi/2012/1916/schedule/27/paragraph/4/made) [5.](/uksi/2012/1916/schedule/27/paragraph/5/made) [The pharmaco-therapeutic group, or type of product,...](/uksi/2012/1916/schedule/27/paragraph/5/made) [7.](/uksi/2012/1916/schedule/27/paragraph/7/made) [A list of\u2014 (a) contra-indications; (b) appropriate precautions for use;...](/uksi/2012/1916/schedule/27/paragraph/7/made) [9.](/uksi/2012/1916/schedule/27/paragraph/9/made) [Instructions for proper use of the product including in particular\u2014...](/uksi/2012/1916/schedule/27/paragraph/9/made) [10.](/uksi/2012/1916/schedule/27/paragraph/10/made) [A description of the adverse reactions which may occur in...](/uksi/2012/1916/schedule/27/paragraph/10/made) [11.](/uksi/2012/1916/schedule/27/paragraph/11/made) [A reference to the expiry date printed on the packaging...](/uksi/2012/1916/schedule/27/paragraph/11/made) [12.](/uksi/2012/1916/schedule/27/paragraph/12/made) [Where the product is authorised under different names in different...](/uksi/2012/1916/schedule/27/paragraph/12/made) [13.](/uksi/2012/1916/schedule/27/paragraph/13/made) [For medicinal products included in the list referred to in...](/uksi/2012/1916/schedule/27/paragraph/13/made) [15.](/uksi/2012/1916/schedule/27/paragraph/15/made) [The date on which the package leaflet [Labelling requirements for registrable immediate packaging](/uksi/2012/1916/schedule/28/part/1/made) [4.](/uksi/2012/1916/schedule/28/paragraph/4/made) [The product's date (month and year), in clear terms....](/uksi/2012/1916/schedule/28/paragraph/4/made) [6.](/uksi/2012/1916/schedule/28/paragraph/6/made) [The contents of the presentation, specified by weight, volume or...](/uksi/2012/1916/schedule/28/paragraph/6/made) [8.](/uksi/2012/1916/schedule/28/paragraph/8/made) [A special warning, if necessary in relation to the product....](/uksi/2012/1916/schedule/28/paragraph/8/made) [11.](/uksi/2012/1916/schedule/28/paragraph/11/made) [The words \"homoeopathic medicinal product Small immediate packaging](/uksi/2012/1916/schedule/28/part/3/made) [21.](/uksi/2012/1916/schedule/28/paragraph/21/made) [The (month and year), in clear terms....](/uksi/2012/1916/schedule/28/paragraph/21/made) [22.](/uksi/2012/1916/schedule/28/paragraph/22/made) [The contents of the presentation, specified by weight, volume or...](/uksi/2012/1916/schedule/28/paragraph/22/made) [24.](/uksi/2012/1916/schedule/28/paragraph/24/made) [The words \"homoeopathic medicinal product without [Labelling of traditional herbal medicinal products](/uksi/2012/1916/schedule/29/made) [PART 2 Traditional herbal medicinal products not subject to general sale](/uksi/2012/1916/schedule/29/part/2/made) [Particulars for advertisements to persons qualified to prescribe or supply](/uksi/2012/1916/schedule/30/made) [1.](/uksi/2012/1916/schedule/30/paragraph/1/made) [The number of the marketing authorisation, certificate of registration, traditional...](/uksi/2012/1916/schedule/30/paragraph/1/made) [5.](/uksi/2012/1916/schedule/30/paragraph/5/made) [A list of the active ingredients of the medicinal product...](/uksi/2012/1916/schedule/30/paragraph/5/made) [6.](/uksi/2012/1916/schedule/30/paragraph/6/made) [One or more of the indications for the medicinal product...](/uksi/2012/1916/schedule/30/paragraph/6/made) [9.](/uksi/2012/1916/schedule/30/paragraph/9/made) [(1) The particulars specified in paragraph 7 must be printed...](/uksi/2012/1916/schedule/30/paragraph/9/made) [3.](/uksi/2012/1916/schedule/31/paragraph/3/made) [If the sample was purchased by the sampling officer otherwise...](/uksi/2012/1916/schedule/31/paragraph/3/made) [4.](/uksi/2012/1916/schedule/31/paragraph/4/made) [If the sampling officer obtained the sample from a vending...](/uksi/2012/1916/schedule/31/paragraph/4/made) [10.](/uksi/2012/1916/schedule/31/paragraph/10/made) [Unless the sampling officer decides not to submit the sample...](/uksi/2012/1916/schedule/31/paragraph/10/made) [11.](/uksi/2012/1916/schedule/31/paragraph/11/made) [If a sample consists of substances or articles in unopened...](/uksi/2012/1916/schedule/31/paragraph/11/made) [12.](/uksi/2012/1916/schedule/31/paragraph/12/made) [Regulation 343(1)(a) to (d) has effect in relation to supplying...](/uksi/2012/1916/schedule/31/paragraph/12/made) [13.](/uksi/2012/1916/schedule/31/paragraph/13/made) [If after reasonable inquiry the sampling officer is unable to...](/uksi/2012/1916/schedule/31/paragraph/13/made) [15.](/uksi/2012/1916/schedule/31/paragraph/15/made) [Where the enforcing authority that authorises the sampling officer is...](/uksi/2012/1916/schedule/31/paragraph/15/made) [16.](/uksi/2012/1916/schedule/31/paragraph/16/made) [Where any other enforcing authority authorises the sampling officer, if...](/uksi/2012/1916/schedule/31/paragraph/16/made) [17.](/uksi/2012/1916/schedule/31/paragraph/17/made) [(1) Arrangements of the kind mentioned in paragraphs 15(b) and...](/uksi/2012/1916/schedule/31/paragraph/17/made) [18.](/uksi/2012/1916/schedule/31/paragraph/18/made) [A laboratory to which a sample is submitted under paragraph...](/uksi/2012/1916/schedule/31/paragraph/18/made) [19.](/uksi/2012/1916/schedule/31/paragraph/19/made) [A laboratory that has analysed or examined a sample submitted...](/uksi/2012/1916/schedule/31/paragraph/19/made) [Transitional provisions and savings](/uksi/2012/1916/schedule/32/made) [Classification of UK marketing authorisation and certificate of registration](/uksi/2012/1916/schedule/32/crossheading/classification-of-uk-marketing-authorisation-and-certificate-of-registration/made) [Medicines for Human Use (Advanced Therapy Medicinal Products and Miscellaneous Amendments) Regulations 2010 (S.I. 2010/1882)](/uksi/2012/1916/schedule/32/crossheading/medicines-for-human-use-advanced-therapy-medicinal-products-and-miscellaneous-amendments-regulations-2010-si-20101882/made) [4.](/uksi/2012/1916/schedule/33/paragraph/4/made) [Regulation 210(3)(g) [7.](/uksi/2012/1916/schedule/33/paragraph/7/made) [The that all reports and updated...](/uksi/2012/1916/schedule/33/paragraph/7/made) [8.](/uksi/2012/1916/schedule/33/paragraph/8/made) [Regulations 186(1)(e) (reporting obligations on licensing [10.](/uksi/2012/1916/schedule/33/paragraph/10/made) [The reference to \"the EMA\" in regulations 191(1) 1 The Medicines Acts 1968 and 1971](/uksi/2012/1916/schedule/34/part/1/made) [2.](/uksi/2012/1916/schedule/34/paragraph/2/made) [For the text of section 1 (Ministers responsible for the...](/uksi/2012/1916/schedule/34/paragraph/2/made) [3.](/uksi/2012/1916/schedule/34/paragraph/3/made) [In section 10 (exemptions for pharmacists)\u2014 (a) in subsection (1)...](/uksi/2012/1916/schedule/34/paragraph/3/made) [4.](/uksi/2012/1916/schedule/34/paragraph/4/made) [In ](/uksi/2012/1916/schedule/34/paragraph/4/made) [6.](/uksi/2012/1916/schedule/34/paragraph/6/made) [In section products as prescription-only...](/uksi/2012/1916/schedule/34/paragraph/6/made) [7.](/uksi/2012/1916/schedule/34/paragraph/7/made) [In section 62 (prohibition of sale or supply, or importation,...](/uksi/2012/1916/schedule/34/paragraph/7/made) [8.](/uksi/2012/1916/schedule/34/paragraph/8/made) [In section 64(5) (protection for purchasers of medicinal products) for...](/uksi/2012/1916/schedule/34/paragraph/8/made) [10.](/uksi/2012/1916/schedule/34/paragraph/10/made) [In section 72 (representative of death...](/uksi/2012/1916/schedule/34/paragraph/10/made) [11.](/uksi/2012/1916/schedule/34/paragraph/11/made) [In section \"Pharmaceutical...](/uksi/2012/1916/schedule/34/paragraph/11/made) [13.](/uksi/2012/1916/schedule/34/paragraph/13/made) [In section 88(1) (distinctive colours, shapes and markings of medicinal...](/uksi/2012/1916/schedule/34/paragraph/13/made) [14.](/uksi/2012/1916/schedule/34/paragraph/14/made) [In section 91 (offences under Part V, and supplementary provisions)\u2014...](/uksi/2012/1916/schedule/34/paragraph/14/made) [15.](/uksi/2012/1916/schedule/34/paragraph/15/made) [In section 104 (application of Act to certain articles and...](/uksi/2012/1916/schedule/34/paragraph/15/made) [16.](/uksi/2012/1916/schedule/34/paragraph/16/made) [In section 105 (application of Act to certain other substances...](/uksi/2012/1916/schedule/34/paragraph/16/made) [17.](/uksi/2012/1916/schedule/34/paragraph/17/made) [In section 107 (validity of decisions and proceedings relating thereto)\u2014...](/uksi/2012/1916/schedule/34/paragraph/17/made) [18.](/uksi/2012/1916/schedule/34/paragraph/18/made) [(1) Section 108 (enforcement in England and Wales) is amended...](/uksi/2012/1916/schedule/34/paragraph/18/made) [19.](/uksi/2012/1916/schedule/34/paragraph/19/made) [In section 109 (enforcement in Scotland)\u2014 (a) (2)\u2014...](/uksi/2012/1916/schedule/34/paragraph/19/made) [21.](/uksi/2012/1916/schedule/34/paragraph/21/made) [In (1)...](/uksi/2012/1916/schedule/34/paragraph/21/made) [22.](/uksi/2012/1916/schedule/34/paragraph/22/made) [In section substance or...](/uksi/2012/1916/schedule/34/paragraph/22/made) [23.](/uksi/2012/1916/schedule/34/paragraph/23/made) [In section 114(1) (supplementary provisions entry...](/uksi/2012/1916/schedule/34/paragraph/23/made) [24.](/uksi/2012/1916/schedule/34/paragraph/24/made) [In section 121(4) (contravention person),...](/uksi/2012/1916/schedule/34/paragraph/24/made) [25.](/uksi/2012/1916/schedule/34/paragraph/25/made) [In section 122(2) (warranty as defence), for the words \"section...](/uksi/2012/1916/schedule/34/paragraph/25/made) [26.](/uksi/2012/1916/schedule/34/paragraph/26/made) [In section 123(1)(b) (offences in relation to warranties certificates...](/uksi/2012/1916/schedule/34/paragraph/26/made) [28.](/uksi/2012/1916/schedule/34/paragraph/28/made) [In section 126 (presumptions)\u2014 (a) in [29.](/uksi/2012/1916/schedule/34/paragraph/29/made) [In in for...](/uksi/2012/1916/schedule/34/paragraph/29/made) [30.](/uksi/2012/1916/schedule/34/paragraph/30/made) [In in subsection (2),...](/uksi/2012/1916/schedule/34/paragraph/30/made) [31.](/uksi/2012/1916/schedule/34/paragraph/31/made) [In section 130 (meaning medicinal product (1)...](/uksi/2012/1916/schedule/34/paragraph/33/made) [PART 2 Other primary legislation](/uksi/2012/1916/schedule/34/part/2/made) [Christmas Day and New Year's Day Trading (Scotland) Act 2007](/uksi/2012/1916/schedule/34/part/2/crossheading/christmas-day-and-new-years-day-trading-scotland-act-2007/made) [PART 3 Northern Ireland Orders in Council](/uksi/2012/1916/schedule/34/part/3/made) [Health and Personal Social Services (Northern Ireland) Order 1972](/uksi/2012/1916/schedule/34/part/3/crossheading/health-and-personal-social-services-northern-ireland-order-1972/made) [PART 4 The Medicines for Human Use (Clinical Trials) Regulations 2004](/uksi/2012/1916/schedule/34/part/4/made) [52.](/uksi/2012/1916/schedule/34/paragraph/52/made) [The Medicines for Human Use (Clinical Trials) Regulations 2004 are...](/uksi/2012/1916/schedule/34/paragraph/52/made) [53.](/uksi/2012/1916/schedule/34/paragraph/53/made) [In regulation [54.](/uksi/2012/1916/schedule/34/paragraph/54/made) [In (responsibility for...](/uksi/2012/1916/schedule/34/paragraph/54/made) [55.](/uksi/2012/1916/schedule/34/paragraph/55/made) [In regulation 19(10) (authorisation [57.](/uksi/2012/1916/schedule/34/paragraph/57/made) [In (application of the Act)\u2014...](/uksi/2012/1916/schedule/34/paragraph/57/made) [58.](/uksi/2012/1916/schedule/34/paragraph/58/made) [In regulation 48(5) (infringement publications) for...](/uksi/2012/1916/schedule/34/paragraph/60/made) [61.](/uksi/2012/1916/schedule/34/paragraph/61/made) [In paragraph 4(2) of Schedule 5 (procedural provisions relating to...](/uksi/2012/1916/schedule/34/paragraph/61/made) [62.](/uksi/2012/1916/schedule/34/paragraph/62/made) [In Schedule 7 (standard provisions for manufacturing authorisations)\u2014 ](/uksi/2012/1916/schedule/34/paragraph/62/made) [63.](/uksi/2012/1916/schedule/34/paragraph/63/made) [In paragraph 5(2) of Schedule 8 (procedural provisions relating to...](/uksi/2012/1916/schedule/34/paragraph/63/made) [64.](/uksi/2012/1916/schedule/34/paragraph/64/made) [For Schedule 9 substitute the following Schedule\u2014 SCHEDULE9 MODIFICATIONS OF...](/uksi/2012/1916/schedule/34/paragraph/64/made) [PART 5 Other United Kingdom, Scotland and Wales Secondary legislation](/uksi/2012/1916/schedule/34/part/5/made) [Medicines (Administration of Radioactive Substances) Regulations 1978](/uksi/2012/1916/schedule/34/part/5/crossheading/medicines-administration-of-radioactive-substances-regulations-1978/made) [Importation of Animal Products and Poultry Products Order 1980](/uksi/2012/1916/schedule/34/part/5/crossheading/importation-of-animal-products-and-poultry-products-order-1980/made) [Medicines Act (Hearings by Persons Appointed) (Scotland) Rules 1986](/uksi/2012/1916/schedule/34/part/5/crossheading/medicines-act-hearings-by-persons-appointed-scotland-rules-1986/made) [Medicines (Fixing of Fees Relating to Medicinal Products for Human Use) Order 1989](/uksi/2012/1916/schedule/34/part/5/crossheading/medicines-fixing-of-fees-relating-to-medicinal-products-for-human-use-order-1989/made) [Medical Devices (Consultation Requirements) (Fees) Regulations 1995](/uksi/2012/1916/schedule/34/part/5/crossheading/medical-devices-consultation-requirements-fees-regulations-1995/made) [General Optical Council (Rules relating to Injury or Disease of the Eye) Order of Council 1999](/uksi/2012/1916/schedule/34/part/5/crossheading/general-optical-council-rules-relating-to-injury-or-disease-of-the-eye-order-of-council-1999/made) [National Health Service (Charges for Drugs and Appliances) Regulations 2000](/uksi/2012/1916/schedule/34/part/5/crossheading/national-health-service-charges-for-drugs-and-appliances-regulations-2000/made) [Medicines (Aristolochia and Mu Tong etc) (Prohibition Order) 2001](/uksi/2012/1916/schedule/34/part/5/crossheading/medicines-aristolochia-and-mu-tong-etc-prohibition-order-2001/made) [Medicines for Human Use (Kava-kava) (Prohibition Order) 2002](/uksi/2012/1916/schedule/34/part/5/crossheading/medicines-for-human-use-kavakava-prohibition-order-2002/made) [Medicines and Healthcare Products Regulatory Agency Trading Fund Order 2003](/uksi/2012/1916/schedule/34/part/5/crossheading/medicines-and-healthcare-products-regulatory-agency-trading-fund-order-2003/made) [Enterprise Act 2002 (Part 8 Community Infringements Specified UK Laws) Order 2003](/uksi/2012/1916/schedule/34/part/5/crossheading/enterprise-act-2002-part-8-community-infringements-specified-uk-laws-order-2003/made) [Enterprise Act 2002 (Part 8 Notice to OFT of Intended Prosecution Specified Enactments, Revocation and Transitional Provision) Order 2003](/uksi/2012/1916/schedule/34/part/5/crossheading/enterprise-act-2002-part-8-notice-to-oft-of-intended-prosecution-specified-enactments-revocation-and-transitional-provision-order-2003/made) [Health Professions (Parts of and Entries in the Register) Order of Council 2003](/uksi/2012/1916/schedule/34/part/5/crossheading/health-professions-parts-of-and-entries-in-the-register-order-of-council-2003/made) [Unlicensed Medicinal Products for Human Use (Transmissible Spongiform Encephalopathies) (Safety) Regulations 2003](/uksi/2012/1916/schedule/34/part/5/crossheading/unlicensed-medicinal-products-for-human-use-transmissible-spongiform-encephalopathies-safety-regulations-2003/made) [National Health Service (General Medical Services Contracts) (Scotland) Regulations 2004](/uksi/2012/1916/schedule/34/part/5/crossheading/national-health-service-general-medical-services-contracts-scotland-regulations-2004/made) [National Health Service (Primary Medical Services Section 17C Agreements) (Scotland) Regulations 2004](/uksi/2012/1916/schedule/34/part/5/crossheading/national-health-service-primary-medical-services-section-17c-agreements-scotland-regulations-2004/made) [National Health Service (General Medical Services Contracts) Regulations 2004](/uksi/2012/1916/schedule/34/part/5/crossheading/national-health-service-general-medical-services-contracts-regulations-2004/made) [National Health Service (General Medical Services Contracts) (Wales) Regulations 2004](/uksi/2012/1916/schedule/34/part/5/crossheading/national-health-service-general-medical-services-contracts-wales-regulations-2004/made) [National Health Service (Personal Medical Services Agreements) Regulations 2004](/uksi/2012/1916/schedule/34/part/5/crossheading/national-health-service-personal-medical-services-agreements-regulations-2004/made) [National Health Service (General Medical Services Contracts) (Prescription of Drugs Etc.) (Wales) Regulations 2004](/uksi/2012/1916/schedule/34/part/5/crossheading/national-health-service-general-medical-services-contracts-prescription-of-drugs-etc-wales-regulations-2004/made) [Contracting Out (Functions relating to Broadcast Advertising) and Specification of Relevant Functions Order 2004](/uksi/2012/1916/schedule/34/part/5/crossheading/contracting-out-functions-relating-to-broadcast-advertising-and-specification-of-relevant-functions-order-2004/made) [General Optical Council (Registration Rules) Order of Council 2005](/uksi/2012/1916/schedule/34/part/5/crossheading/general-optical-council-registration-rules-order-of-council-2005/made) [National Health Service (Free Prescriptions and Charges for Drugs and Appliances) (Wales) Regulations 2007](/uksi/2012/1916/schedule/34/part/5/crossheading/national-health-service-free-prescriptions-and-charges-for-drugs-and-appliances-wales-regulations-2007/made) [Human Tissue (Quality and Safety for Human Application) Regulations 2007](/uksi/2012/1916/schedule/34/part/5/crossheading/human-tissue-quality-and-safety-for-human-application-regulations-2007/made) [Legislative and Regulatory Reform (Regulatory Functions) Order 2007](/uksi/2012/1916/schedule/34/part/5/crossheading/legislative-and-regulatory-reform-regulatory-functions-order-2007/made) [Medicines for Human Use (Prohibition) (Senecio and Miscellaneous Amendments) Order 2008](/uksi/2012/1916/schedule/34/part/5/crossheading/medicines-for-human-use-prohibition-senecio-and-miscellaneous-amendments-order-2008/made) [Health Service Branded Medicines (Control of Prices and Supply of Information) (No 2) Regulations 2008](/uksi/2012/1916/schedule/34/part/5/crossheading/health-service-branded-medicines-control-of-prices-and-supply-of-information-no-2-regulations-2008/made) [National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009](/uksi/2012/1916/schedule/34/part/5/crossheading/national-health-service-pharmaceutical-services-scotland-regulations-2009/made) [Co-ordination of Regulatory Enforcement (Regulatory Functions in Scotland and Northern Ireland) Order 2009](/uksi/2012/1916/schedule/34/part/5/crossheading/coordination-of-regulatory-enforcement-regulatory-functions-in-scotland-and-northern-ireland-order-2009/made) [PART 6 Northern Ireland statutory rules](/uksi/2012/1916/schedule/34/part/6/made) [Prison and Young Offenders Centre (Amendment) Rules (Northern Ireland) 1995](/uksi/2012/1916/schedule/34/part/6/crossheading/prison-and-young-offenders-centre-amendment-rules-northern-ireland-1995/made) [Diseases of Animals (Importation of Bird Products) Order (Northern Ireland) 1996](/uksi/2012/1916/schedule/34/part/6/crossheading/diseases-of-animals-importation-of-bird-products-order-northern-ireland-1996/made) [Industrial Pollution Control (Prescribed Processes and Substances) Regulations (Northern Ireland) 1998](/uksi/2012/1916/schedule/34/part/6/crossheading/industrial-pollution-control-prescribed-processes-and-substances-regulations-northern-ireland-1998/made) [Products of Animal Origin (Import and Export) Regulations (Northern Ireland) 1998](/uksi/2012/1916/schedule/34/part/6/crossheading/products-of-animal-origin-import-and-export-regulations-northern-ireland-1998/made) [Importation of Animal Pathogens Order (Northern Ireland) 1999](/uksi/2012/1916/schedule/34/part/6/crossheading/importation-of-animal-pathogens-order-northern-ireland-1999/made) [Control of Substances Hazardous to Health Regulations (Northern Ireland) 2003](/uksi/2012/1916/schedule/34/part/6/crossheading/control-of-substances-hazardous-to-health-regulations-northern-ireland-2003/made) [Waste Management Licensing Regulations (Northern Ireland) 2003](/uksi/2012/1916/schedule/34/part/6/crossheading/waste-management-licensing-regulations-northern-ireland-2003/made) [Health and Personal Social Services (General Medical Services Contracts) Regulations (Northern Ireland) 2004](/uksi/2012/1916/schedule/34/part/6/crossheading/health-and-personal-social-services-general-medical-services-contracts-regulations-northern-ireland-2004/made) [Healthy Start Scheme and Day Care Food Scheme Regulations (Northern Ireland) 2006](/uksi/2012/1916/schedule/34/part/6/crossheading/healthy-start-scheme-and-day-care-food-scheme-regulations-northern-ireland-2006/made) [Avian Influenza and Influenza of Avian Origin in Mammals Regulations (Northern Ireland) 2007](/uksi/2012/1916/schedule/34/part/6/crossheading/avian-influenza-and-influenza-of-avian-origin-in-mammals-regulations-northern-ireland-2007/made) [Residential Family Centres Regulations (Northern Ireland) 2007](/uksi/2012/1916/schedule/34/part/6/crossheading/residential-family-centres-regulations-northern-ireland-2007/made) [Natural Mineral Water, Spring Water and Bottled Drinking Water Regulations (Northern Ireland) 2007](/uksi/2012/1916/schedule/34/part/6/crossheading/natural-mineral-water-spring-water-and-bottled-drinking-water-regulations-northern-ireland-2007/made) [Controlled Drugs (Supervision of Management and Use) Regulations (Northern Ireland) 2009](/uksi/2012/1916/schedule/34/part/6/crossheading/controlled-drugs-supervision-of-management-and-use-regulations-northern-ireland-2009/made) The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run. Would you like to continue? The Whole Instrument you have selected contains over 200 provisions and might take some time to download. Would you like to continue? The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run. Would you like to continue? The Whole Instrument without Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run. Would you like to continue? The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run. Would you like to continue? Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the 'Changes to Legislation' area. Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text. Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards. Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand: Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include: Click 'View More' or select "}